Urenco Board approval of Tails Management Facility
25 July 2011 Global NewsThe Urenco Board reaffirmed its commitment to the building of a Tails Management Facility at the Group’s UK site based at Capenhurst near Chester.
Urenco readily acknowledges its responsibility for the safe stewardship of uranium. In this respect, a comprehensive review of the project resulted in approval being given to move from the design phase to full execution, with the commencement of construction in early 2012. It is anticipated that the facility will become fully operational towards the end of 2015.
On completion, the Tails Management Facility will process Urenco’s European inventory of depleted uranium by-product reflecting the Group’s commitment to reducing its impact on the environment.
More global stories
Urenco helps fund new science centre at Chester Zoo to fight global extinction crisis
Global 08 November 2024The centre, which is triple the size of the zoo’s previous lab facilities, will now enable it to significantly expand its scientific capacity, particularly in conservation.
Read moreThe centre, which is triple the size of the zoo’s previous lab facilities, will now enable it to significantly expand its scientific capacity, particularly in conservation.
Read moreUrenco signs new contracts with Czechia’s ČEZ
Global 07 November 2024We will supply the energy company with enriched uranium from our European sites well into the 2030s as part of a new agreement.
Read moreWe will supply the energy company with enriched uranium from our European sites well into the 2030s as part of a new agreement.
Read moreAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries